Galectin Therapeutics Inc. (GALT) NASDAQ

4.22

-0.33(-7.25%)

Updated at September 29 04:00PM

Currency In USD

Valuation

Market Cap80.38M
Enterprise Value171.5M
P/E Ratio-6.64
PEG Ratio-0.6
Price/Sales Ratio7,508.22
Price/Book Ratio-2.29
Enterprise/Revenue10,473.19
Enterprise/EBITDA-11.25

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1,120.53
Operating Margin-944.89

Management Effectiveness

Return On Assets-2.59
Return On Equity0.38

Income Statement

Revenue0
Revenue/Share0
Gross Profit-37,000
EBITDA-41.47M
Net Income-47.05M
Diluted EPS-0.76

Balance Sheet

Total Cash13.77M
Total Cash/Share0.22
Total Debt120.51M
Total Debt/Equity-1.03
Current Ratio1.43
Book Value Per Share-1.85

Price History

52-Week Change53.45
52-Week High6.55
52-Week Low0.73
Moving Average 50 Days4.06
Moving Average 200 Days2.17

Statistics

Average Volume318,203
Shares Outstanding64.05M
% Held by Institutions16.55

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor1:6
Last Split DateMarch 23, 2012